Clinical Trial Update: A First in Human Study of RT001 in Patients With Friedreich's Ataxia [Phase 1, Phase 2]

View source ↗

Summary

First-in-human study of RT001 in Friedreich's Ataxia completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• RT001

Snippet

Sponsor: Biojiva LLC | Conditions: Friedreich's Ataxia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-27